Table 2 Results of the Delphi survey on antimicrobial agents to be included and on methods for data extraction for antibiotic quality assessment
Items | Agree (%) | Disagree (%) | Neutral (%) | CVR |
|---|---|---|---|---|
The range of antimicrobial agents that can be included (currently) | ||||
Antibacterial agents | 19 (100.0) | 0 | 0 | 1.000 |
Antifungal agents | 6 (33.3) | 1 (5.6) | 11 (61.1) | − 0.333 |
Antiviral agents | 2 (11.1) | 5 (27.8) | 11 (61.1) | − 0.778 |
Anti-TB, protozoal, malarial agents | 0 | 12 (66.7) | 6 (33.3) | − 1.000 |
Systemic antibiotics (IV, oral) | 19 (100.0) | 0 | 0 | 1.000 |
Local antibiotics (nebuliser, ointment, etc.) | 1 (5.3) | 12 (63.2) | 6 (31.6) | − 0.895 |
The range of antimicrobial agents that can be included (in the future) | ||||
Antibacterial agents | 19 (100.0) | 0 | 0 | 1.000 |
Antifungal agents | 16 (88.9) | 0 | 2 (11.1) | 0.778 |
Antiviral agents | 12 (66.7) | 2 (11.1) | 4 (22.2) | 0.333 |
Anti-TB, protozoal, malarial agents | 2 (11.1) | 4 (22.2) | 12 (66.7) | − 0.778 |
Systemic antibiotics (IV, oral) | 19 (100.0) | 0 | 0 | 1.000 |
Local antibiotics (nebuliser, ointment, etc.) | 3 15.8 | 9 47.4 | 7 36.8 | − 0.684 |
Types of antibiotics based on the purpose of the antibiotic prescription (currently) | ||||
Therapeutic | 19 (100.0) | 0 | 0 | 1.000 |
Surgical prophylaxis | 19 (100.0) | 0 | 0 | 1.000 |
Medical prophylaxis | 17 (89.5) | 0 | 2 (10.5) | 0.789 |
Antibiotics for community acquired infection | 19 (100.0) | 0 | 0 | 1.000 |
Antibiotics for healthcare-associated infection | 19 (100.0) | 0 | 0 | 1.000 |
Types of antibiotics based on the purpose of the antibiotic prescription (in the future) | ||||
Therapeutic | 19 (100.0) | 0 | 0 | 1.000 |
Surgical prophylaxis | 19 (100.0) | 0 | 0 | 1.000 |
Medical prophylaxis | 19 (100.0) | 0 | 0 | 1.000 |
Antibiotics for community acquired infection | 19 (100.0) | 0 | 0 | 1.000 |
Antibiotics for healthcare-associated infection | 19 (100.0) | 0 | 0 | 1.000 |
Methods for quality assessment of antibiotics (based on expert opinion, specific criteria [quality indicators]) | ||||
Evaluation based on expert judgement (not based on specific criteria) | 10 (52.6) | 2 (10.5) | 7 (36.8) | 0.053 |
Evaluation using systematised criteria (quality indicators) | 19 (100.0) | 0 | 0 | 1.000 |
The need for regular revision of quality indicators developed through consensus of domestic expert groups | 19 (100.0) | 0 | 0 | 1.000 |
How to extract targeted antibiotics for inclusion in a qualitative antibiotic assessment (currently) | ||||
Evaluation of a random sample of antibiotics prescribed on a given day (without considering the duration of antibiotic use) | 15 (78.9) | 2 (10.5) | 2 (10.5) | 0.579 |
Evaluation of all antibiotics prescribed on a given day (without considering the duration of antibiotic use) | 4 (21.1) | 5 (26.3) | 10 (52.6) | − 0.579 |
Randomised evaluation of antibiotics prescribed in a specific period (considering the duration of antibiotic use) | 19 (100.0) | 0 | 0 | 1.000 |
Evaluation of all antibiotics prescribed in a specific period (considering the duration of antibiotic use) | 6 (31.6) | 3 (15.8) | 10 (52.6) | − 0.368 |
Evaluation of antibiotics prescribed at a specific point in time for a specific disease or for a specific antibiotic (census or randomised) | 14 (77.8) | 2 (11.1) | 3 (16.7) | 0.556 |
Combining an assessment of antibiotics prescribed in a specific period with an assessment of specific antibiotics or conditions as needed (all or randomised) | 16 (84.2) | 2 (10.5) | 1 (5.3) | 0.684 |
How to extract targeted antibiotics for inclusion in a qualitative antibiotic assessment (in the future) | ||||
Evaluation of a random sample of antibiotics prescribed on a given day (without considering the duration of antibiotic use) | 8 (42.1) | 3 (15.8) | 8 (42.1) | − 0.158 |
Evaluation of all antibiotics prescribed on a given day (without considering the duration of antibiotic use) | 9 (47.4) | 4 (21.1) | 6 (31.6) | − 0.053 |
Randomised evaluation of antibiotics prescribed in a specific period (considering the duration of antibiotic use) | 18 (94.7) | 0 | 1 (5.3) | 0.895 |
Evaluation of all antibiotics prescribed in a specific period (considering the duration of antibiotic use) | 17 (89.5) | 1 (5.3) | 1 (5.3) | 0.789 |
Evaluation of antibiotics prescribed at a specific point in time for a specific disease or for a specific antibiotic (census or randomised) | 8 (42.1) | 1 (5.3) | 10 (52.6) | − 0.158 |
Combining an assessment of antibiotics prescribed in a specific period with an assessment of specific antibiotics or conditions as needed (all or randomised) | 18 (94.7) | 1 (5.3) | 0 | 0.895 |